Clinical pharmacokinetics of clarithromycin

KA Rodvold - Clinical pharmacokinetics, 1999 - Springer
Clarithromycin is a macrolide antibacterial that differs in chemical structure from
erythromycin by the methylation of the hydroxyl group at position 6 on the lactone ring. The …

Macrolide antibacterials: drug interactions of clinical significance

NA von Rosenstiel, D Adam - Drug Safety, 1995 - Springer
Macrolide antibiotics can interact adversely with commonly used drugs, usually by altering
metabolism due to complex formation and inhibition of cytochrome P-450 IIIA4 (CYP3A4) in …

[PDF][PDF] Макролиды в современной клинической практике

ЛС Страчунский, СН Козлов - Смоленск: Русич, 1998 - microbius.ru
В книге представлены современные подходы к клиническому применению макролидов,
занимающих одну из ведущих позиций среди антибиотиков, исходя из их …

Quantitative determination of the macrolide antibiotics erythromycin, roxithromycin, azithromycin and clarithromycin in human serum by high-performance liquid …

JS Torano, HJ Guchelaar - … of Chromatography B: Biomedical Sciences and …, 1998 - Elsevier
A validated, highly sensitive and precise high-performance liquid chromatographic (HPLC)
method for the determination of the macrolides erythromycin, azithromycin, clarithromycin …

Chromatography as an analytical tool for selected antibiotic classes: a reappraisal addressed to pharmacokinetic applications

A Marzo, L Dal Bo - Journal of Chromatography A, 1998 - Elsevier
The first antibiotic discovered, penicillin, appeared on the market just after the Second World
War. Intensive research in subsequent years led to the discovery and development of …

Pharmacokinetic considerations in the treatment of inflammatory bowel disease

M Schwab, U Klotz - Clinical pharmacokinetics, 2001 - Springer
This review describes the pharmacokinetics of the major drugs used for the treatment of
inflammatory bowel disease. This information can be helpful for the selection of a particular …

Comparison of bronchopulmonary pharmacokinetics of clarithromycin and azithromycin

KB Patel, D Xuan, PR Tessier… - Antimicrobial Agents …, 1996 - Am Soc Microbiol
The bronchopulmonary and plasma pharmacokinetics of clarithromycin (CLA; 500 mg given
twice daily for nine doses) or azithromycin (AZ; 500 mg for the first dose and then 250 mg …

Formulation and evaluation of gastroretentive dosage forms of clarithromycin

M Nama, CSR Gonugunta, P Reddy Veerareddy - Aaps PharmSciTech, 2008 - Springer
The purpose of this research was to develop the hydrodynamically balanced delivery system
of Clarithromycin (CLA) which, after oral administration should have the ability to prolong …

[HTML][HTML] An in vitro study of dual drug combinations of anti-viral agents, antibiotics, and/or hydroxychloroquine against the SARS-CoV-2 virus isolated from hospitalized …

A Miatmoko, E Hendrianto, D Karsari, A Dinaryanti… - Plos one, 2021 - journals.plos.org
A potent therapy for the infectious coronavirus disease COVID-19 is urgently required with,
at the time of writing, research in this area still ongoing. This study aims to evaluate the in …

Pharmacokinetic Considerations in the Eradication of Helicobacter Pylori

U Klotz - Clinical pharmacokinetics, 2000 - Springer
As Helicobacter pylori plays an important role in the aetiopathogenesis of peptic ulcer,
therapeutic strategies aimed at maintaining long term remission have shifted from the control …